Svidinskaya Svidinskaya

Dr. Svidinskaya Svidinskaya


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
SBSh.N. Bortsvadze
Sh.N. Bortsvadze
SSSvidinskaya Svidinskaya
Svidinskaya Svidinskaya
TDT.A. Dzhibladze
T.A. Dzhibladze
VZV.M. Zuev
V.M. Zuev
IKI.D. Khokhlova
I.D. Khokhlova

7 October 2024 in V.F.Snegirev Archives of Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
DKDaria V. Korolyova
Daria V. Korolyova
SYSofia A. Yakunina
Sofia A. Yakunina
VSVladislav V. Shemyakin
Vladislav V. Shemyakin
SSSvidinskaya Svidinskaya
Svidinskaya Svidinskaya
ESElena A. Sosnova
Elena A. Sosnova
ЯАЯкунина Софья Андреевна
Якунина Софья Андреевна
Postpartum depression has become an increasingly urgent problem of modern medicine and psychology. This condition is a mental disorder that causes emotional, behavioral, and physical changes associated with the postpartum period. Despite the presence of a wide range of signs, the diagnosis of postpartum depression remains challenging for specialists. A woman experiencing this type of depression may find it difficult to realize her condition on her own and seek help. However, even if properly diagnosed, the fact of having postpartum depression can be a negative experience for a woman. Young mothers often feel fear or shame in front of family members and the society and hide their diagnosis. This creates additional barriers to getting the necessary help and support. This review aimed to identify and analyze risk factors of depressive disorders in women in the postpartum period and investigate some manifestations of postpartum depression. The scientific databases CyberLeninkа, eLibrary, and PubMed were used. The articles were searched for the following keywords: “postpartum period,” “depressive disorder,” “postpartum depression,” “postpartum depression and risk factors,” and “development of depressive disorders in the postpartum period.” The study included articles published over the past 5 years. After sampling by annotations and keywords, 53 articles were analyzed: 6 Russian and 47 English speakers. The risk factors described in modern domestic and foreign literature were analyzed and were classified as unmodified and modifiable, which was further characterized as modifiable by the mother and/or her family and modifiable only by healthcare.

1 January 2022 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
SSSvidinskaya Svidinskaya
Svidinskaya Svidinskaya
ALA.V. Lysenko
A.V. Lysenko
GBG.V. Brykin
G.V. Brykin
Представлен обзор российской и зарубежной литературы, рассматривающей особенности клинической картины, основные теории патогенеза, традиционные и инновационные методы диагностики и хирургического лечения катмениального пневмоторакса (КП). Многолетнее изучение КП оставило множество нерешенных вопросов из-за малой распространенности и неверной диагностики этого заболевания. Рентгенологическое исследование органов грудной клетки не всегда выявляет специфические для КП признаки, компьютерная томография достаточно информативна, но слабо специфична, она остается методом визуализации первой линии. В последнее время в качестве основного метода диагностики клиницисты предпочитают использовать магнитно-резонансную томографию и торакоскопию. Идет активный поиск лабораторных методов диагностики, способных подтвердить эндометриоидную природу пневмоторакса: это онкомаркер СА-125, определение стволовых клеток эндометрия в кровотоке (EPCs), снижение экспрессии гена HOXA10. Лечение КП и предотвращение его рецидива — спорный момент, зависящий как от клинической картины, так и от предпочтений лечащего врача. Большинство авторов придерживаются мнения, что терапия торакального эндометриоза и КП должна быть комплексной и включать не только устранение пневмоторакса, но и хирургическое лечение первичного поражения матки с последующим обязательным назначением противорецидивной гормональной терапии. Считается, что сочетание гормональной терапии и резекции диафрагмы позволяет добиться оптимального противорецидивного эффекта.

30 June 2022 in V.F.Snegirev Archives of Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
SSSvidinskaya Svidinskaya
Svidinskaya Svidinskaya
MAMikhail B. Ageev
Mikhail B. Ageev
NPNatalya V. Paleeva
Natalya V. Paleeva
VMValeria A. Mukhaeva
Valeria A. Mukhaeva
ESElena A. Sosnova
Elena A. Sosnova
МАМухаева Валерия Арифовна
Мухаева Валерия Арифовна
This study aimed to review the modern literature on the problems of adolescent obesity and the pathogenesis of menstrual dysfunction in overweight adolescents and women of reproductive age. In recent years, a large number of works have been published on the relationship of hyperinsulinemia with ovarian hyperandrogenism. Most authors recognize that insulin resistance and hyperinsulinemia contribute to polycystic ovary syndrome formation. The formation of menstrual disorders in overweight girls is based on the violation of gonadotropin secretion, insulin resistance, and hyperinsulinemia, which over time lead to hyperandrogenism. A decreased level of somatotropic hormone and insulin-like growth factor and an increased level of leptin leads to malfunctions in the correct functioning of the hypothalamic-pituitary system. These changes disturb the ovulatory function and, consequently, adolescent reproductive health. The relationship between obesity and depression is actively discussed by foreign authors, and the obtained results often contradict each other. Most studies suggest that excessive weight gain during adolescence can lead to depression, negative mood, and low self-esteem. This study analyzes the results of research by domestic and foreign authors on the issues of diagnosis and treatment. Menstrual disorder therapy against the background of overweight adolescent girls is a matter of dispute among clinicians. With weight loss in adolescents, a significant improvement is found in carbohydrate and lipid metabolism, decreased levels of hepatic transaminases, and a decreased severity of obstructive sleep apnea syndrome.

28 March 2022 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
DDDzhibladze T.A. Dzhibladze
Dzhibladze T.A. Dzhibladze
ZZZuev V.M. Zuev
Zuev V.M. Zuev
IIIshchenko A.I. Ishchenko
Ishchenko A.I. Ishchenko
SSSvidinskaya Svidinskaya
Svidinskaya Svidinskaya
KKKhokhlova I.D. Khokhlova
Khokhlova I.D. Khokhlova
PPPutilo A.O. Putilo
Putilo A.O. Putilo

1 January 2025 in Voprosy Ginekologii, Akušerstva i Perinatologii
Verified
Journal Article
Closed access
MPM.V. Poznyak
M.V. Poznyak
VKV.A. Kaptilnyy
V.A. Kaptilnyy
RCR.A. Chilova
R.A. Chilova
DLD.V. Lystsev
D.V. Lystsev
MAM.B. Ageev
M.B. Ageev
GSG.E. Sevostianov
G.E. Sevostianov
The Papanicolaou staining method and primary cervical screening for HPV are widely used to detect precancerous conditions and cervical cancer. Patients diagnosed with ASCUS/LSIL are at risk for progression of dysplasia (CIN2+) and require follow-up monitoring. The prognosis for HPV-positive women remains uncertain, necessitating refinement of tests to predict outcomes of persistent HPV infection. Therefore, an effective biomarker is needed to separate patients based on the results of pre-cervical screening. Two oncoproteins can be used for this purpose: p16 acts as a cell cycle regulatory protein that induces cell cycle arrest, and Ki-67, which is a marker of cell proliferation. They are not expressed in cervical epitheliocytes under physiological conditions. The simultaneous identification of these two proteins during additional staining of cytological preparations suggests the presence of cell cycle dysregulation mediated by persistent HPV infection and is also a predictor of the development of severe cervical lesions. The sensitivity of this test for the diagnosis of moderate and severe cervical dysplasia was found to be high; p16/Ki-67 dual immunostaining has comparable sensitivity and increased specificity for CIN2+ screening compared with the detection of high-risk HPV types. This review reflects the value of p16/Ki-67 dual staining in cervical cytology in distinguishing patients with existing cervical dysplasia. Key words: p16/Ki-67 co-expression, cytology, HPV, cervical screening, CIN